Which dosage forms of secobarbital must be ordered using a DEA Form 222?

Secobarbital is classified as a Schedule II controlled substance due to its potential for abuse and dependence. When dealing with Schedule II controlled substances, the Drug Enforcement Administration (DEA) requires that specific ordering procedures are followed to ensure proper tracking and accountability of these medications.

Injectable forms of secobarbital are considered the most regulated due to the immediate and potent effects associated with parenteral administration, which can lead to higher risks of misuse. As a result, the ordering of injectable forms necessitates the completion of a DEA Form 222, which is specifically designed for the purchase of Schedule II substances. This form serves as a record that allows the DEA to monitor prescriptions and transactions involving highly controlled medications.

It is important to note that while other dosage forms, including oral tablets and capsules, are also categorized as Schedule II, not all may require a DEA Form 222 for ordering. Typically, oral formulations of Schedule II substances can be obtained through more straightforward prescription processes under certain conditions. However, the key factor for injectable dosage forms is the heightened regulatory scrutiny they undergo, necessitating the use of the DEA Form 222 for their acquisition.